AQP1 and chronic kidney disease: Tubular SA-β-gal activity has been associated with accelerated loss of kidney function in CKD patients with different etiologies [42], although our study is the first to establish tubular segment specificity using the fluorescent Spider-β-gal probe and co-staining for PTEC marker AQP-1.